Organism name | Urtica dioica |
---|---|
Genus | Urtica |
Family | Urticaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Urtica dioica |
---|---|
Linked NCBI taxonomy ID | 3501 |
Linked level | species |
Family in NCBI taxonomy | Urticaceae |
---|---|
ID | 3499 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
Species | Activity |
---|---|
Urtica dioica L. | 5-Lipoxygenase Inhibitor |
Urtica dioica L. | Analgesic |
Urtica dioica L. | Anesthetic |
Urtica dioica L. | Anti-HIV |
Urtica dioica L. | Antiadrenaline |
Urtica dioica L. | Antiallergic |
Urtica dioica L. | Antiaromatase |
Urtica dioica L. | Antiarthritic |
Urtica dioica L. | Antiasthmatic |
Urtica dioica L. | Antibacterial |
Urtica dioica L. | Anticancer |
Urtica dioica L. | Anticomplementary |
Urtica dioica L. | Anticonvulsant |
Urtica dioica L. | Antiedemic |
Urtica dioica L. | Antiexudative |
Urtica dioica L. | Antihemorrhagic |
Urtica dioica L. | Antihidrotic |
Urtica dioica L. | Antihistaminic |
Urtica dioica L. | Antiinflammatory |
Urtica dioica L. | Antileukotriene |
Urtica dioica L. | Antiprostatitic |
Urtica dioica L. | Antipyretic |
Urtica dioica L. | Antirheumatic |
Urtica dioica L. | Antiseptic |
Urtica dioica L. | Antispasmodic |
Urtica dioica L. | Antitumor |
Urtica dioica L. | Antiviral |
Urtica dioica L. | Aphrodisiac |
Urtica dioica L. | Aquaretic |
Urtica dioica L. | Aromatase Inhibitor |
Urtica dioica L. | Astringent |
Urtica dioica L. | Bitter |
Urtica dioica L. | Bleeding |
Urtica dioica L. | Bradycardic |
Urtica dioica L. | CNS Depressant |
Urtica dioica L. | Cyclooxygenase Inhibitor |
Urtica dioica L. | Cytotoxic |
Urtica dioica L. | Depurative |
Urtica dioica L. | Diuretic |
Urtica dioica L. | Elastase Inhibitor |
Urtica dioica L. | Emmenagogue |
Urtica dioica L. | Expectorant |
Urtica dioica L. | Fungicide |
Urtica dioica L. | Hematogenic |
Urtica dioica L. | Hemostat |
Urtica dioica L. | Histaminic |
Urtica dioica L. | Hyperglycemic |
Urtica dioica L. | Hypoglycemic |
Urtica dioica L. | Hypotensive |
Urtica dioica L. | Inteferonigenic |
Urtica dioica L. | Lactagogue |
Urtica dioica L. | Laxative |
Urtica dioica L. | Litholytic |
Urtica dioica L. | Mitogenic |
Urtica dioica L. | Myorelaxant |
Urtica dioica L. | Pancreatonic |
Urtica dioica L. | Rubefacient |
Urtica dioica L. | Tonic |
Urtica dioica L. | Uterotonic |
Urtica dioica L. | Vasoconstrictor |
Urtica dioica L. | Vermifuge |
Urtica dioica L. | Vulnerary |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00007190
![]() |
(+)-Pinoresinol
|
CHEMBL267963
CHEMBL487611 CHEMBL460862 |
C103298
|
7 / 5 / 6 | No. 38 | No. 21 |
![]() |
|
C00000604
![]() |
(-)-Secoisolariciresinol
|
CHEMBL368347
|
C060283
|
2 / 1 / 1 | 1 / 0 | No. 282 | No. 21 |
![]() |
C00007204
![]() |
Isolariciresinol
/ (+)-Isolariciresinol |
CHEMBL399512
CHEMBL1760593 |
C060284
|
2 / 1 / 1 | No. 406 |
![]() |
||
C00002591
![]() |
(-)-Cubebin
/ beta-Cubebin / (-)-beta-Cubebin / (8R,8'R,9S)-Cubebin |
CHEMBL182001
CHEMBL399831 |
C433065
|
2 / 1 / 1 | 0 / 2 | No. 629 | No. 21 |
![]() |
C00001429
![]() |
Serotonin
/ Enteramin / Enteramine / DS substance / Thrombotonin / Thrombocytin / 5-Hydroxytryptamine |
CHEMBL39
CHEMBL1628597 |
D012701
|
78 / 35 / 22 | 32 / 40 | No. 1910 | No. 4 |
![]() |
C00002685
![]() |
Acetophenone
|
CHEMBL274467
|
C038699
|
2 / 0 / 0 | 2 / 0 | No. 2578 | No. 9 |
![]() |
C00001414
![]() |
Histamine
|
CHEMBL90
|
D006632
|
30 / 21 / 20 | 63 / 40 | No. 4250 |
![]() |
|
C00001182
![]() |
Formic acid
|
CHEMBL116736
|
C030544
|
7 / 1 | No. 7874 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000604 C00001414 C00001429 C00002591 C00007204 | 1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000604 C00001414 C00001429 C00002591 C00007204 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001414 C00001429 | 0 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001414 C00001429 | 1 / 1 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00001414 C00001429 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001414 C00001429 | 2 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00001414 C00001429 | 0 / 0 |
O75751 | Solute carrier family 22 member 3 | Unclassified protein | C00001414 C00001429 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001414 C00001429 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001429 C00007190 | 0 / 3 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001414 C00001429 | 0 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001414 C00001429 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001414 C00001429 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001414 C00001429 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001414 C00001429 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00001414 C00001429 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001414 C00001429 | 1 / 2 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001414 C00001429 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001414 C00001429 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001414 C00001429 | 0 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001414 C00001429 | 1 / 2 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001414 C00001429 | 3 / 2 |
P14679 | Tyrosinase | Oxidoreductase | C00001429 | 4 / 2 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001414 | 0 / 0 |
P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001429 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001414 | 0 / 0 |
P34969 | 5-hydroxytryptamine receptor 7 | Serotonin receptor | C00001429 | 0 / 0 |
P47898 | 5-hydroxytryptamine receptor 5A | Serotonin receptor | C00001429 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001414 | 11 / 10 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00001429 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001429 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001429 | 0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001414 | 0 / 0 |
P05164 | Myeloperoxidase | Enzyme | C00001429 | 1 / 2 |
P28566 | 5-hydroxytryptamine receptor 1E | Serotonin receptor | C00001429 | 0 / 0 |
Q13464 | Rho-associated protein kinase 1 | Rock | C00002685 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00007190 | 0 / 0 |
P49286 | Melatonin receptor type 1B | Melatonin receptor | C00001429 | 0 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001429 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00001429 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001429 | 1 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001429 | 0 / 0 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001429 | 0 / 0 |
Q9Y5N1 | Histamine H3 receptor | Histamine receptor | C00001414 | 0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | C00002685 | 0 / 0 |
Q9H3N8 | Histamine H4 receptor | Histamine receptor | C00001414 | 0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001414 | 0 / 0 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001429 | 1 / 1 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001429 | 2 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00007190 | 5 / 3 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001429 | 0 / 0 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001429 | 0 / 0 |
P48039 | Melatonin receptor type 1A | Melatonin receptor | C00001429 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001429 | 0 / 0 |
Q13639 | 5-hydroxytryptamine receptor 4 | Serotonin receptor | C00001429 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00007190 | 0 / 0 |
P06133 | UDP-glucuronosyltransferase 2B4 | Enzyme | C00001429 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001429 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001429 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001429 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001429 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00007190 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001414 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00001429 | 5 / 1 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00001429 | 0 / 0 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00001429 | 1 / 0 |
P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001429 | 0 / 0 |
Q07869 | Peroxisome proliferator-activated receptor alpha | NR1C1 | C00007190 | 0 / 0 |
P30939 | 5-hydroxytryptamine receptor 1F | Serotonin receptor | C00001429 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00001429 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00001414 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001429 | 0 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00001429 | 1 / 0 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001429 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001429 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001429 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001429 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001429 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001429 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001429 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001429 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001429 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001429 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001429 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001429 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001429 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001429 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001429 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001429 | 1 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001429 | 3 / 0 |
Q8WXA8 | 5-hydroxytryptamine receptor 3C | NS | C00001429 | 0 / 0 |
Q70Z44 | 5-hydroxytryptamine receptor 3D | NS | C00001429 | 0 / 0 |
O95264 | 5-hydroxytryptamine receptor 3B | NS | C00001429 | 0 / 0 |
A5X5Y0 | 5-hydroxytryptamine receptor 3E | NS | C00001429 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00007190 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001414
C00001429
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001414
C00001429
|
6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00001414
C00001429
|
6570 | SLC18A1, CGAT, VAT1, VMAT1 | solute carrier family 18 (vesicular monoamine transporter), member 1 |
C00001414
C00001429
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001414
C00001429
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001414
C00001429
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001429
|
217 | ALDH2, ALDH-E2, ALDHI, ALDM | aldehyde dehydrogenase 2 family (mitochondrial) (EC:1.2.1.3) |
C00002685
|
250 | ALPP, ALP, PALP, PLAP, PLAP-1 | alkaline phosphatase, placental (EC:3.1.3.1) |
C00002685
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000604
|
25 | ABL1, ABL, JTK7, bcr/abl, c-ABL, p150, v-abl | c-abl oncogene 1, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00001414
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001414
|
240 | ALOX5, 5-LO, 5-LOX, 5LPG, LOG5 | arachidonate 5-lipoxygenase (EC:1.13.11.34) |
C00001414
|
241 | ALOX5AP, FLAP | arachidonate 5-lipoxygenase-activating protein |
C00001414
|
26 | AOC1, ABP, ABP1, DAO, DAO1, KAO | amine oxidase, copper containing 1 (EC:1.4.3.22) |
C00001414
|
362 | AQP5, AQP-5, PPKB | aquaporin 5 |
C00001414
|
613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00001414
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00001414
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00001414
|
929 | CD14 | CD14 molecule |
C00001414
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00001414
|
941 | CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7 | CD80 molecule |
C00001414
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00001414
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00001414
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00001414
|
1179 | CLCA1, CACC, CACC1, CLCRG1, CaCC-1, GOB5, hCLCA1, hCaCC-1 | chloride channel accessory 1 |
C00001414
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00001414
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001414
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00001414
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00001414
|
2205 | FCER1A, FCE1A, FcERI | Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide |
C00001414
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001414
|
2990 | GUSB, BG, MPS7 | glucuronidase, beta (EC:3.2.1.31) |
C00001414
|
3067 | HDC | histidine decarboxylase (EC:4.1.1.22) |
C00001414
|
3176 | HNMT, HMT, HNMT-S1, HNMT-S2 | histamine N-methyltransferase (EC:2.1.1.8) |
C00001414
|
3269 | HRH1, H1-R, hisH1 | histamine receptor H1 |
C00001414
|
3274 | HRH2, H2R | histamine receptor H2 |
C00001414
|
11255 | HRH3, GPCR97, HH3R | histamine receptor H3 |
C00001414
|
59340 | HRH4, AXOR35, BG26, GPCR105, GPRv53, H4, H4R, HH4R | histamine receptor H4 |
C00001414
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00001414
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00001414
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00001414
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00001414
|
1356 | CP, CP-2 | ceruloplasmin (ferroxidase) (EC:1.16.3.1) |
C00001182
|
3603 | IL16, LCF, NIL16, PRIL16, prIL-16 | interleukin 16 |
C00001414
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00001414
|
3567 | IL5, EDF, IL-5, TRF | interleukin 5 (colony-stimulating factor, eosinophil) |
C00001414
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001182
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001182
|
3785 | KCNQ2, BFNC, BFNS1, EBN, EBN1, EIEE7, ENB1, HNSPC, KCNA11, KV7.2, KVEBN1 | potassium voltage-gated channel, KQT-like subfamily, member 2 |
C00001414
|
3786 | KCNQ3, BFNC2, EBN2, KV7.3 | potassium voltage-gated channel, KQT-like subfamily, member 3 |
C00001414
|
4056 | LTC4S | leukotriene C4 synthase (EC:4.4.1.20) |
C00001414
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001414
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00001414
|
4312 | MMP1, CLG, CLGN | matrix metallopeptidase 1 (interstitial collagenase) (EC:3.4.24.7) |
C00001414
|
4586 | MUC5AC, MUC5, TBM, leB | mucin 5AC, oligomeric mucus/gel-forming |
C00001414
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00001414
|
4843 | NOS2, HEP-NOS, INOS, NOS, NOS2A | nitric oxide synthase 2, inducible (EC:1.14.13.39) |
C00001414
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00001414
|
5321 | PLA2G4A, PLA2G4, cPLA2-alpha | phospholipase A2, group IVA (cytosolic, calcium-dependent) (EC:3.1.1.5 3.1.1.4) |
C00001414
|
5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00001414
|
5563 | PRKAA2, AMPK, AMPK2, AMPKa2, PRKAA | protein kinase, AMP-activated, alpha 2 catalytic subunit (EC:2.7.11.1 2.7.11.27 2.7.11.31) |
C00001414
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001414
|
5788 | PTPRC, B220, CD45, CD45R, GP180, L-CA, LCA, LY5, T200 | protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48) |
C00001414
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001414
|
5172 | SLC26A4, DFNB4, EVA, PDS, TDH2B | solute carrier family 26 (anion exchanger), member 4 |
C00001182
|
4953 | ODC1, ODC | ornithine decarboxylase 1 (EC:4.1.1.17) |
C00001182
|
6581 | SLC22A3, EMT, EMTH, OCT3 | solute carrier family 22 (organic cation transporter), member 3 |
C00001414
|
6794 | STK11, LKB1, PJS, hLKB1 | serine/threonine kinase 11 (EC:2.7.11.1) |
C00001414
|
6863 | TAC1, Hs.2563, NK2, NKNA, NPK, TAC2 | tachykinin, precursor 1 |
C00001414
|
7097 | TLR2, CD282, TIL4 | toll-like receptor 2 |
C00001414
|
3064 | HTT, HD, IT15 | huntingtin |
C00001182
|
7351 | UCP2, BMIQ4, SLC25A8, UCPH | uncoupling protein 2 (mitochondrial, proton carrier) |
C00001414
|
7422 | VEGFA, MVCD1, VEGF, VPF | vascular endothelial growth factor A |
C00001182
|
1080 | CFTR, ABC35, ABCC7, CF, CFTR/MRP, MRP7, TNR-CFTR, dJ760C5.1 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) (EC:3.6.3.49) |
C00001429
|
2597 | GAPDH, G3PD, GAPD | glyceraldehyde-3-phosphate dehydrogenase (EC:1.2.1.12) |
C00001429
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00001429
|
3352 | HTR1D, 5-HT1D, HT1DA, HTR1DA, HTRL, RDC4 | 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
C00001429
|
3356 | HTR2A, 5-HT2A, HTR2 | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
C00001429
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00001429
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00001429
|
3363 | HTR7, 5-HT7 | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
C00001429
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001429
|
3690 | ITGB3, BDPLT16, BDPLT2, CD61, GP3A, GPIIIa, GT | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) |
C00001429
|
4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001429
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001429
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001429
|
85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00001429
|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001429
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001429
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001429
|
6814 | STXBP3, MUNC18-3, MUNC18C, PSP, UNC-18C | syntaxin binding protein 3 |
C00001429
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001429
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001429
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001429
|
7166 | TPH1, TPRH, TRPH, TPH | tryptophan hydroxylase 1 (EC:1.14.16.4) |
C00001429
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00001429
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00001429
|
7498 | XDH, XO, XOR | xanthine dehydrogenase (EC:1.17.1.4 1.17.3.2) |
C00001429
|
OMIM | preferred title | UniProt |
---|---|---|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P14416
P31645 P47869 |
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
%606641 | Body mass index; bmi |
P37231
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#159900 | Myoclonic dystonia |
P14416
|
#601665 | Obesity |
P37231
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
Q16790 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00038 | Malignant melanoma |
P14679
(marker)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00769 | Hyperekplexia |
P23415
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
P49286 (related) |
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D010146 | Pain |
C00002591
C00001414 C00001429 |
D012640 | Seizures |
C00001414
C00001429 |
D006930 | Hyperalgesia |
C00001414
C00001429 |
D013276 | Stomach Ulcer |
C00001414
C00001429 |
D004487 | Edema |
C00002591
C00001429 |
D011537 | Pruritus |
C00001414
C00001429 |
D009135 | Muscular Diseases |
C00001414
C00001429 |
D007022 | Hypotension |
C00001414
C00001429 |
D002389 | Catatonia |
C00001414
C00001429 |
D003643 | Death |
C00001182
|
D003233 | Conjunctivitis, Allergic |
C00001414
|
D003329 | Coronary Vasospasm |
C00001414
|
D004342 | Drug Hypersensitivity |
C00001414
|
D056486 | Drug-Induced Liver Injury |
C00001414
|
D004417 | Dyspnea |
C00001414
|
D004802 | Eosinophilia |
C00001414
|
D004890 | Erythema |
C00001414
|
D006261 | Headache |
C00001414
|
D001986 | Bronchial Spasm |
C00001414
|
D006967 | Hypersensitivity |
C00001414
|
D006968 | Hypersensitivity, Delayed |
C00001414
|
D006969 | Hypersensitivity, Immediate |
C00001414
|
D006975 | Hypertension, Portal |
C00001414
|
D001862 | Bone Resorption |
C00001414
|
D007410 | Intestinal Diseases |
C00001414
|
D034701 | Mastocytosis, Cutaneous |
C00001414
|
D008545 | Melanoma |
C00001414
|
D008569 | Memory Disorders |
C00001414
|
D008881 | Migraine Disorders |
C00001414
|
D055963 | Asthma, Aspirin-Induced |
C00001414
|
D009203 | Myocardial Infarction |
C00001414
|
D010149 | Pain, Postoperative |
C00001414
|
D001249 | Asthma |
C00001414
|
D011833 | Radiation Injuries, Experimental |
C00001414
|
D012130 | Respiratory Hypersensitivity |
C00001414
|
D012220 | Rhinitis |
C00001414
|
D001145 | Arrhythmias, Cardiac |
C00001414
|
D012771 | Shock, Hemorrhagic |
C00001414
|
D012772 | Shock, Septic |
C00001414
|
D000799 | Angioedema |
C00001414
|
D014456 | Ulcer |
C00001414
|
D014581 | Urticaria |
C00001414
|
D000544 | Alzheimer Disease |
C00001429
|
D000648 | Amnesia, Retrograde |
C00001429
|
D001008 | Anxiety Disorders |
C00001429
|
D001022 | Aortic Valve Insufficiency |
C00001429
|
D001049 | Apnea |
C00001429
|
D001281 | Atrial Fibrillation |
C00001429
|
D001321 | Autistic Disorder |
C00001429
|
D001919 | Bradycardia |
C00001429
|
D002375 | Catalepsy |
C00001429
|
D002659 | Child Development Disorders, Pervasive |
C00001429
|
D021081 | Chronobiology Disorders |
C00001429
|
D015140 | Dementia, Vascular |
C00001429
|
D003967 | Diarrhea |
C00001429
|
D004195 | Disease Models, Animal |
C00001429
|
D005355 | Fibrosis |
C00001429
|
D005483 | Flushing |
C00001429
|
D006349 | Heart Valve Diseases |
C00001429
|
D006973 | Hypertension |
C00001429
|
D006976 | Hypertension, Pulmonary |
C00001429
|
D017379 | Hypertrophy, Left Ventricular |
C00001429
|
D007249 | Inflammation |
C00001429
|
D043183 | Irritable Bowel Syndrome |
C00001429
|
D008944 | Mitral Valve Insufficiency |
C00001429
|
D009336 | Necrosis |
C00001429
|
D009422 | Nervous System Diseases |
C00001429
|
D020230 | Serotonin Syndrome |
C00001429
|
D013226 | Status Epilepticus |
C00001429
|
D020521 | Stroke |
C00001429
|
D013610 | Tachycardia |
C00001429
|
D059246 | Tachypnea |
C00001429
|
D014202 | Tremor |
C00001429
|